ReproCELL Incorporated Logo

ReproCELL Incorporated

Provider of stem cell technology and services for research and regenerative medicine.

4978 | T

Overview

Corporate Details

ISIN(s):
JP3974770004
LEI:
Country:
Japan
Address:
横浜市港北区新横浜3−8−11

Description

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-13 07:35
確認書
Japanese ZIP 8.1 KB
2025-11-13 07:35
半期報告書-第24期(2025/04/01-2026/03/31)
Japanese ZIP 219.0 KB
2025-06-26 02:41
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 23.4 KB
2025-06-26 02:41
確認書
Japanese ZIP 8.1 KB
2025-06-26 02:40
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 1.1 MB
2024-11-13 07:31
確認書
Japanese ZIP 8.1 KB
2024-11-13 07:31
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese ZIP 221.1 KB
2024-06-26 03:02
臨時報告書
Japanese ZIP 28.0 KB
2024-06-25 07:31
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 22.2 KB
2024-06-25 07:30
確認書
Japanese ZIP 8.2 KB
2024-06-25 07:29
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese ZIP 1.2 MB
2024-05-23 08:02
臨時報告書
Japanese ZIP 20.0 KB
2024-02-09 07:24
確認書
Japanese ZIP 8.2 KB
2024-02-09 07:23
四半期報告書-第22期第3四半期(2023/10/01-2023/12/31)
Japanese ZIP 227.6 KB
2023-11-10 07:05
四半期報告書-第22期第2四半期(2023/07/01-2023/09/30)
Japanese ZIP 213.2 KB

Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ReproCELL Incorporated

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Hoth Therapeutics, Inc. Logo
A clinical-stage biopharma company advancing drugs for unmet medical needs.
United States of America
HOTH
Human Stem Cells Institute PJSC Logo
Develops gene therapies, vaccines, medical devices, and genetic testing systems.
Russian Federation
ISKJ
HVIVO PLC Logo
A contract research organization specializing in human challenge trials for biopharma.
United Kingdom
HVO
Hybrigenics SA Logo
Provider of technologies for studying molecular interactions and antibody selection.
France
ALHYG
A contract research organization providing clinical trial services with a focus on oncology.
South Korea
187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Develops antiviral and anticancer drugs using a proprietary drug delivery system.
South Korea
048410
ICON PLC Logo
Global provider of outsourced development services for pharma, biotech & medical device.
United States of America
ICLR
IGC Pharma, Inc. Logo
Clinical-stage biotech firm developing AI-driven treatments for Alzheimer's disease.
United States of America
IGC
IMCB PJSC Logo
Biotechnology company specializing in personal stem cell banking and genetic testing.
Russian Federation
GEMA
Immuneering Corp Logo
Clinical-stage oncology company developing medicines using computational technology.
United States of America
IMRX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.